platinum-based chemo doublets: backbone for nsclc treatment
Published 8 years ago • 2K plays • Length 3:40Download video MP4
Download video MP3
Similar videos
-
3:17
platinum-based doublets as the cornerstone of first line treatment
-
6:57
lung cancer video library - chemo immuno therapy combinations in advanced nsclc
-
4:02
ros1 nsclc: chemotherapy and immunotherapy -
-
1:59:57
grace - global resource for advancing cancer education live stream
-
3:25
checkmate 816: neoadjuvant nivolumab chemotherapy for nsclc - onctalk lung 2023
-
6:35
elderly patients: single agent vs. doublet chemotherapy
-
6:52
combination chemotherapy and immunotherapy for patients with high pd-l1 nsclc - 2022 program: lcvl
-
4:56
dual immune checkpoint blockade with or without chemotherapy - lung cancer onctalk 2022
-
0:31
biomarkers in nsclc - targeted therapies in lung cancer 2023 - #youtubeshorts #shorts
-
2:18
treatment of stage iv nsclc with high pd-l1 and atypical mutation - lung cancer onctalk 2022
-
6:38
asco 2021 lung recap: poseidon trial: durvalumab /- tremelimumab vs. chemo alone
-
8:13
checkmate 816: combining chemo and opdivo - asco lung review 2022
-
2:31
gracecastuc-004 - why is chemotherapy recommended for most patients with nsclc?
-
2:22
aegean trial: perioperative durvalumab for nsclc - onctalk lung 2023
-
6:40:28
full video ondemand -targeted therapies patient forum 2022 - for those living with lung cancer
-
16:03
grace targeted therapies lung cancer 2021 -the role of chemotherapy in driver positive patients
-
7:39
chemotherapy and immunotherapy for patients with kras mutations - asco lung review 2022
-
4:35
immunotherapy combinations
-
4:35
maintenance therapy for advanced nsclc